Here's Why Axovant Sciences Lost as Much as 29.2% Today [The Motley Fool]
Axon Enterprise, Inc. (AXON)
Last axon enterprise, inc. earnings: 2/7 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.axovant.com/investors/sec-filings
Company Research
Source: The Motley Fool
The biopharma's wild year continues with another clinical failure, but it won't have much impact on the company's future. Maxx Chatsko ( TMFBlacknGold ) Dec 10, 2018 at 1:35PM What happened Shares of Axovant Sciences ( NASDAQ:AXON ) dropped over 29% today after the company announced that nelotanserin failed a phase 2 clinical trial investigating its potential to treat REM sleep disorder in patients with a certain type of dementia. It was the company's lone small-molecule drug candidate remaining after it went all-in developing gene therapies for psychological ailments in summer 2018. In that context, today's news isn't as much of a setback as the stock's plunge seems to indicate. The biopharma's future will be determined by the success or failure of its entirely new pipeline of early-stage assets, although with the most mature program in phase 1
Show less
Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXON alerts
High impacting Axon Enterprise, Inc. news events
Weekly update
A roundup of the hottest topics
AXON
News
- Will Axon (AXON) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Here's Why Axon Enterprise (AXON) is a Strong Growth Stock [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise (AXON) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise Insiders Placed Bullish Bets Worth US$8.74m [Yahoo! Finance]Yahoo! Finance
- Earnings Growth & Price Strength Make Axon Enterprise (AXON) a Stock to Watch [Yahoo! Finance]Yahoo! Finance
AXON
Earnings
- 2/27/24 - Beat
AXON
Sec Filings
- 4/19/24 - Form POSASR
- 4/15/24 - Form DEFA14A
- 4/15/24 - Form DEFA14A
- AXON's page on the SEC website